PMID: 12124743

Salvatore F, Scudiero O, Castaldo G
Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Am J Med Genet. 2002 Jul 22;111(1):88-95., 2002-07-22 [PubMed]
Sentences
No. Mutations Sentence Comment
18 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12124743:18:56
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 12124743:18:232
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Tyr122*
X
ABCC7 p.Tyr122* 12124743:18:145
status: NEW
view ABCC7 p.Tyr122* details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 12124743:18:194
status: NEW
view ABCC7 p.Thr338Ile details
Several mutations are frequent in specific populations: W1282X among Ashkenazi [Shoshani et al., 1992], 2143delT in Germany [Dork et al., 1994], Y122X in Iceland [Chevalier-Porst et al., 1994], T338I in Sardinia, and 2183AA > G and R1162X in Northeast Italy [Rendine et al., 1997]. Login to comment
25 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12124743:25:117
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 12124743:25:149
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12124743:25:160
status: NEW
view ABCC7 p.Gly542* details
Several mutations of this group have a frequency of > 2% among CF chromosomes within most populations studied, e.g., W1282X [Shoshani et al., 1992], R553X, and G542X [Casals et al., 1993]. Login to comment
28 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12124743:28:80
status: NEW
view ABCC7 p.Gly551Asp details
Class 3 mutations affect the regulatory domains of the CFTR protein and include G551D, which is frequent in Northern Europe. Login to comment
46 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12124743:46:185
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 12124743:46:269
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 12124743:46:248
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 12124743:46:382
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 12124743:46:206
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 12124743:46:234
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 12124743:46:220
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Arg347Leu
X
ABCC7 p.Arg347Leu 12124743:46:227
status: NEW
view ABCC7 p.Arg347Leu details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 12124743:46:366
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 12124743:46:241
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 12124743:46:199
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 12124743:46:173
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 12124743:46:262
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 12124743:46:213
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 12124743:46:350
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 12124743:46:342
status: NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 12124743:46:310
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Gly91Arg
X
ABCC7 p.Gly91Arg 12124743:46:179
status: NEW
view ABCC7 p.Gly91Arg details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 12124743:46:326
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Ser492Phe
X
ABCC7 p.Ser492Phe 12124743:46:255
status: NEW
view ABCC7 p.Ser492Phe details
ABCC7 p.Glu193Lys
X
ABCC7 p.Glu193Lys 12124743:46:192
status: NEW
view ABCC7 p.Glu193Lys details
ABCC7 p.Cys866Tyr
X
ABCC7 p.Cys866Tyr 12124743:46:303
status: NEW
view ABCC7 p.Cys866Tyr details
ABCC7 p.Asp579Gly
X
ABCC7 p.Asp579Gly 12124743:46:276
status: NEW
view ABCC7 p.Asp579Gly details
ABCC7 p.His1054Asp
X
ABCC7 p.His1054Asp 12124743:46:318
status: NEW
view ABCC7 p.His1054Asp details
ABCC7 p.Phe1286Ser
X
ABCC7 p.Phe1286Ser 12124743:46:374
status: NEW
view ABCC7 p.Phe1286Ser details
ABCC7 p.Ser1159Pro
X
ABCC7 p.Ser1159Pro 12124743:46:358
status: NEW
view ABCC7 p.Ser1159Pro details
A series of mutations usually associated with pancreatic sufficiency have been identified and defined as ''mild`` with reference to pancreatic status [Kerem et al., 1989c]: G85E, G91R, R117H, E193K, P205S, R334W, T338I, R347H, R347L, R347P, R352Q, A455E, S492F, S549N, P574H, D579G, 711 þ 5 G > A, C866Y, F1052V, H1054D, R1066H, R1068H, H1085R, D1152H, S1159P, S1251N, F1286S, G1349D, 2789 þ 5 G > A, and 3849 þ 10kb C > T [Dean et al., 1990; Cutting et al., 1990a; Cremonesi et al., 1992; Highsmith et al., 1994]. Login to comment
59 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 12124743:59:125
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 12124743:59:135
status: NEW
view ABCC7 p.Ala455Glu details
Several findings suggest that the pulmonary phenotype is directly related to the CFTR genotype: 1) missense mutations (e.g., R117H and A455E) give rise to a milder pulmonary expression [Gan et al., 1995; De Braekeleer et al., 1997]; 2) CF patient homozygotes for DF508 and compound heterozygotes for DF508 and a nonsense mutation at the level of the nucleotide binding folder (NBF) encoding region of the CFTR gene are more susceptible to P. aeruginosa infections [Kubesch et al., 1993; Davidson et al., 1995]; and 3) CF patient homozygotes for DF508 invariably have a severe pulmonary phenotype [Johansen et al., 1991]. Login to comment
65 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 12124743:65:367
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12124743:65:401
status: NEW
view ABCC7 p.Gly542* details
Secondly, pulmonary expression was heterogeneous in CF patient homozygotes for nonsense mutations, although CFTR mRNA was not detected at the pulmonary level in these patients [Hamosh et al., 1991]; for example, a mild pulmonary expression has been reported in several patient homozygotes for nonsense mutations [Cutting et al., 1990b; Cuppens et al., 1990], such as R553X [Castaldo et al., 1996] and G542X [Castaldo et al., 1997]. Login to comment
66 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12124743:66:92
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 12124743:66:185
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 12124743:66:267
status: NEW
view ABCC7 p.Arg1158* details
On the contrary, a severe pulmonary phenotype was reported in 16 CF patient homozygotes for W1282X [Shoshani et al., 1992], and more recently in the first CF patient homozygote for the R1158X nonsense mutation [Castaldo et al., 1999], while a double heterozygote for R1158X showed a mild phenotype [Frossard et al., 2000]. Login to comment
87 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12124743:87:56
status: NEW
view ABCC7 p.Gly542* details
Similarly, we described a CF patient homozygous for the G542X mutation who had a very severe liver phenotype, unlike the six previously reported cases with this CFTR genotype, who were free of liver involvement [Castaldo et al., 1997]. Login to comment
97 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 12124743:97:52
status: NEW
view ABCC7 p.Gly551Asp details
After gene cloning, Hamosh et al. [1992] found that G551D carried a decreased risk of meconium ileus in contrast to previous studies [Kerem et al., 1989c]. Login to comment